Sort
51,593 grants matching “hepatitis”
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
$486,640Tatiana Kisseleva · University Of California, San Diego · R01 · FY2023 · DK
Modeling DENV Infection and PRINT-NP Based DENV Vaccines in Humanized Mice
$486,611Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Ventromedial Hypothalamic Regulation of Metabolic Changes Induced by Exercise
$486,573Joel K Elmquist · Ut Southwestern Medical Center · P01 · FY2020 · DK
Predictive Dosimetry and Metabolism Core
$486,560Jordan Ned Smith · Oregon State University · P42 · FY2025 · ES
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients
$486,540Lynn Pulliam · Northern California Institute/Res/Edu · R01 · FY2017 · MH
Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions
$486,389Mary E McCaul · Johns Hopkins University · P50 · FY2020 · AA
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling
$486,389Shaodong Guo · Texas A&M Agrilife Research · R01 · FY2024 · DK
Regulation of drug metabolizing enzymes by miRNAs
$486,378Todd C. Skaar · Indiana University Indianapolis · R01 · FY2015 · GM
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
$486,374Benjamin P Linas · Boston Medical Center · R01 · FY2014 · DA
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$486,324Andrea L Cox · Johns Hopkins University · U19 · FY2024 · AI
APJ receptor agonism for metabolic syndrome
$486,222Rangan Maitra · Research Triangle Institute · R01 · FY2021 · DK
APJ receptor agonism for metabolic syndrome
$486,222Rangan Maitra · Research Triangle Institute · R01 · FY2020 · DK
APJ receptor agonism for metabolic syndrome
$486,222Rangan Maitra · Research Triangle Institute · R01 · FY2019 · DK
Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons
$486,205Michael D Stein · Butler Hospital (Providence, Ri) · R01 · FY2017 · AA
BMP inhibitors and the study of disease mechanisms in anemia of inflammation
$486,185Randall T Peterson · Massachusetts General Hospital · R01 · FY2009 · DK
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
$486,174John D Groopman · Johns Hopkins University · P01 · FY2011 · ES
PROTEIN SYNTHESIS IN NORMAL AND REGENERATING LIVER
$486,150David A Shafritz · Albert Einstein College Of Medicine · R01 · FY2006 · DK
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$486,146Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
$486,109Peter Igarashi · Ut Southwestern Medical Center · RC1 · FY2010 · DK
Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities
$486,084Olveen Carrasquillo · University Of Miami School Of Medicine · U01 · FY2018 · MD
A multipronged, mRNA gene therapy approach to HIV cure
$486,057Edward Kreider · University Of Pennsylvania · DP2 · FY2025 · AI
Host response and liver disease in a hepatitis C-like virus rat model
$486,029Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AI
HUMAN LIVER CYTOCHROMES P450
$486,003La Jolla Inst For Molecular Medicine · R01 · FY2000 · GM
TTC39B in Metabolism
$486,000Alan Richard Tall · Columbia University Health Sciences · R01 · FY2019 · HL
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
$485,923Colin Neal Young · George Washington University · R01 · FY2021 · DK